Abstract
The antianginal and antiarrhythmic activities of bergamottine, a furocoumarin, were investigated in various in vivo and in vitro test models and have been compared with those of verapamil, a well-known Ca-antagonistic drug. Bergamottine significantly decreased the typical electrocardiographic signs of coronary arterial spasm and the incidence of cardiac arrhythmias induced by pitressin in anaesthetized guinea-pigs. Bergamottine also increased the dose of ouabain required to cause ventricular premature beats, ventricular tachyarrhythmias and lethality. Bergamottine further reversed ouabain-induced persistent ventricular tachycardia and restored sinus rhythm in the guinea-pig. On isolated rat heart, bergamottine exerted a coronary dilator action and was able to reduce the hyperkinetic ventricular arrhythmias caused by post-ischaemic reperfusion. These results demonstrate that bergamottine possesses significant antianginal and antiarrhythmic properties and suggest that this furocoumarin is one of the active components responsible for the cardiovascular activity previously exhibited by non-volatile bergamot oil.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
